Antigenic divergence of Bordetella pertussis isolates in Taiwan

Journal of Clinical Microbiology

Volumn 43, Issue 11, 2005, Pages 5457-5461

  Yao, Shu Man ^a   Lin, Yu Chi ^a   Chou, Chen Ying ^a   Chen, Ying Yan ^a   Hsiao, Miao Ju ^a   Chen, Hour Young ^a   Yan, Jer Jea ^b   Su, Hsun Pi ^a   Li, Shu Ying ^a,b  

^a Research and Diagnostic Center   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANTIGENIC DIVERGENCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CLASSIFICATION; EPIDEMIC; GENE EXPRESSION; GENE SEQUENCE; MOLECULAR EVOLUTION; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PRN GENE; PTXS1 GENE; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; VACCINATION;

ALLELES; ANTIGENIC VARIATION; BASE SEQUENCE; BORDETELLA PERTUSSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; HUMANS; TAIWAN; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 27744463320     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.11.5457-5461.2005     Document Type: Article

References (25)

1. Advani, A., D. Donnelly, and H. Hallander. 2004. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J. Clin. Microbiol. 42:2890-2897.
2. Bisgard, K. M., C. D. Christie, S. F. Reising, G. N. Sanden, P. K. Cassiday, C. Gomersall, W. A. Wattigney, N. E. Roberts, and P. M. Strebel. 2001. Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J. Infect. Dis. 183:1360-1367.
3. Cassiday, P., G. Sanden, K. Heuvelman, F. Mooi, K. M. Bisgard, and T. Popovic. 2000. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J. Infect. Dis. 182: 1402-1408.
4. de Melker, H. E., M. A. Conyn-van Spaendonck, H. C. Rumke, J. K. van Wijngaarden, F. R. Mooi, and J. F. Schellekens. 1997. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg. Infect. Dis. 3:175-178.
5. de Melker, H. E., J. F. Schellekens, S. E. Neppelenbroek, F. R. Mooi, H. C. Rumke, and M. A. Conyn-van Spaendonck. 2000. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerg. Infect. Dis. 6:348-357.
6. Fry, N. K., S. Neal, T. G. Harrison, E. Miller, R. Matthews, and R. C. George. 2001. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun. 69:5520-5528.
7. Hardwick, T. H., P. Cassiday, R. S. Weyant, K. M. Bisgard, and G. N. Sanden. 2002. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis. 8:44-49.
8. He, Q., J. Makinen, G. Berbers, F. R. Mooi, M. K. Viljanen, H. Arvilommi, and J. Mertsola. 2003. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J. Infect. Dis. 187:1200-1205.
9. Hsu, M. C., K. W. Chen, H. J. Lo, Y. C. Chen, M. H. Liao, Y. H. Lin, and S. Y. Li. 2003. Species identification of medically important fungi by use of real-time LightCycler PCR. J. Med. Microbiol. 52:1071-1076.
10. Kerr, J. R., and R. R. Matthews. 2000. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect. Dis. 19:77-88.
11. Kodama, A., K. Kamachi, Y. Horiuchi, T. Konda, and Y. Arakawa. 2004. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J. Clin. Microbiol. 42:5453-5457.
12. Lai, H. K., and S. F. Tsai. 2000. Epidemiology of pertussis in Taiwan, 1993-1998, and its control measures. Epidemiol. Bull. 16:255-281.
13. Lee, Y. S., C. Y. Yang, C. H. Lu, and Y. H. Tseng. 2003. Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997. Microbiol. Immunol. 47:903-909.
14. Mooi, F. R., H. Hallander, C. H. Wirsing von Konig, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19: 174-181.
15. Mooi, F. R., Q. He, H. van Oirschot, and J. Mertsola. 1999. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67:3133-3134.
16. Mooi, F. R., I. H. van Loo, and A. J. King. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526-528.
17. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. van der Heide, W. Gaastra, and R. J. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P. 69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675.
18. Njamkepo, E., F. Rimlinger, S. Thiberge, and N. Guiso. 2002. Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine 20:1290-1294.
19. Peppler, M. S., S. Kuny, A. Nevesinjac, C. Rogers, Y. R. de Moissac, K. Knowles, M. Lorange, G. De Serres, and J. Talbot. 2003. Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994. J. Clin. Microbiol. 41:3344-3347.
20. Poynten, M., P. B. McIntyre, F. R. Mooi, K. J. Heuvelman, and G. L. Gilbert. 2004. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol. Infect. 132:185-193.
21. Robinson, A., L. I. Irons, and L. A. Ashworth. 1985. Pertussis vaccine: present status and future prospects. Vaccine 3:11-22.
22. van Amersfoorth, S. C., L. M. Schouls, H. G. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. von Konig, M. Riffelmann, C. Vahrenholz, N. Guiso, V. Caro, E. Njamkepo, Q. He, J. Mertsola, and F. R. Mooi. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43:2837-2843.
23. van Loo, I. H., K. J. Heuvelman, A. J. King, and F. R. Mooi. 2002. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol. 40:1994-2001.
24. van Loo, I. H., H. G. van der Heide, N. J. Nagelkerke, J. Verhoef, and F. R. Mooi. 1999. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179:915-923.
25. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.